CHMP anbefalede derfor, at afsnit 4. 2 (Dosering og indgivelsesmåde) i produktresumeet bør ændres i overensstemmelse hermed.
Therefore the CHMP recommended that section 4.2 (Posology and Method of Administration) of the SPC should be amended accordingly.